CANCER BUZZ

Association of Cancer Care Centers

CANCER BUZZ features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

  1. -12 H

    A Patient and Her Care Team on Trust + Clinical Trials

    Clinical research is critical to the development of life saving treatments. And ACCC has long supported equitable access to clinical trials, including efforts to ensure that these trials reflect the diversity of the populations they serve. ACCC has made the Just ASK™ Training Program and Site Self-Assessment available free-of-charge to help research sites address barriers to participation in cancer clinical trials among racial and ethnic populations. In this episode, CANCER BUZZ facilities a candid conversation with Glyniss Redman, who received treatment at Gibbs Cancer Center and Research Institute for multiple myeloma, and 2 members of her cancer treatment team: clinical research coordinator Audrianna Carrington and oncologist hematologist Dr. Tondre Buck, about overcoming barriers, ensuring shared decision-making, and improving the inclusion of historically underrepresented groups in clinical trials.   “If you look at cancers in general, treatments have gotten better over the years in almost every category, and we wouldn’t be here if it wasn’t for clinical trials.” – Tondre Buck, MD   “We’re playing the long game here. Some of the information or this research may not be about me. This is about our future generation…so this is a legacy game for me…This is what I’m doing with my [one] wild and precious life. I want to be here as long as I possibly can, but I also want my offspring: my children, my grandchildren, and my great grandchildren to be here as well and [to] have a better experience as far as health care and cancer.” – Glyniss Redman   “We do have to talk about past unethical experimentation and research in order for us to better prepare how we're going to go forward…[transportation] is one barrier that we are tackling. You know, we don't want to put that stress on the patients who have to choose between gas, their physician visit, their food, or their medicine for the day. So that is a huge barrier, and you really want that population to be represented on the trial, because rural populations tend to have higher cancer rates.” – Audrianna Carrington   Tondre Buck, MD Oncologist Hematologist Gibbs Cancer Center and Research Institute Spartanburg, SC   Audrianna Carrington Clinical Research Coordinator Gibbs Cancer Center and Research Institute Spartanburg, SC   Glyniss Redman Poet and Patient with Multiple Myeloma   Resources:   The Just ASK™ Training Program, Site Self-Assessment, and Training Facilitation Guide   ACORI Call to Action Summit   Clinical Research Terms Glossary   Increasing Clinical Trial Accrual Through the Implementation of a Clinical Trials Navigator   Gibbs Cancer Center and Research Institute   Cancer Moonshot Biobank   National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data   TalkAboutTrials.com

    28 min
  2. 26 AOÛT

    Increasing Access and Representation in Clinical Trials

    Clinical trials are vital to offering and developing the most effective treatment options. However, there are large disparities in enrollment across race, ethnicity, geography, and type of cancer care center. Mary Bird Perkins Cancer Center in Baton Rouge, LA uses local partnerships, culturally tailored outreach, and workforce innovation to drive sustainable and equitable participation in clinical trials. Minorities now make up 21% of their clinical trial participation, surpassing the national average. Following these meaningful gains in attracting local minority populations and underserved communities to take part in clinical trials, the Mary Bird Perkins research team received a grant to further support this work. In this episode of CANCER BUZZ, Victor Lin, MD, PhD, research medical director at Mary Bird Perkins Cancer Center, shares strategies for success in their community, including awareness campaigns and partnerships. CANCER BUZZ also speaks with TaeJeanne “TJ” Taylor-Lawrence, RN, registered nurse and patient navigator, about building relationships and supporting patients in clinical trials.     “We really, really have to be thinking, from a trial design standpoint, about the barriers that we're throwing up in the name of trying to keep the science and the data clean.” - Victor Lin, MD, PhD    “There's been this long-standing perception that cancer clinical trials are really the domain of only academic cancer centers. But I think increasingly we're finding that ... community cancer centers can be more nimble and are perfectly capable of running the same trials and seeing these patients where they live.” - Victor Lin, MD, PhD    “I think that representation builds trust. If people don't see themselves in this process, whether it's in the data, whether it's in the staff, or any of the outreach programs that we have, they're just less likely to believe that this is for them. In my community, black and brown communities especially, I think there's a deep need to feel seen, respected, and understood. When a patient sees someone that looks like them or shares their background talking about clinical trials, I think that that shifts the energy.” - TaeJeanne “TJ” Taylor-Lawrence, RN    “If the research does not reflect all of us, the solutions won't either.” - TaeJeanne “TJ” Taylor-Lawrence, RN    Victor Lin, MD, PhD Research Medical Director Mary Bird Perkins Cancer Center Baton Rouge, LA   TaeJeanne “TJ” Taylor-Lawrence, RN Registered Nurse Mary Bird Perkins Cancer Center Baton Rouge, LA   Resources: ACCC Community Oncology Research Institute (ACORI) Bringing Cancer Research to the Community:  Strategic Approaches to Representative Oncology Clinical Trial Design Mary Bird Perkins Cancer Center Receives $400,000 Grant to Continue Expansion of Nationally-Recognized Clinical Trials Program

    17 min
  3. 5 AOÛT

    Transforming Cancer Detection and Treatment

    In this episode, CANCER BUZZ speaks with Bart Daugherty, vice president of clinical technology and systems at Georgetown Cancer Center, Lifepoint Health, about his program’s receipt of a 2025 ACCC Innovator Award. Lifepoint’s innovation, Transforming Cancer Detection and Treatment with the AI-Driven Healthy Person Program, leverages artificial intelligence (AI) to analyze the health records of all patients who have received care at Lifepoint Health’s facilities and identify those who are at risk of developing catastrophic diseases. This initiative, dubbed the Healthy Person Program, has already impacted over 280,000 patients since the deployment of Lifepoint’s AI tool and made significant strides in improving population health in its communities.    Bart Daugherty  Vice President, Clinical Technology and Systems  Lifepoint Health  Brentwood, Tennessee    “We’ve taken a lot of the administrative burden off of [our cancer team] and allowed them to focus on critical patient [cases].”  – Bart Daugherty    This podcast is part of a special series featuring the 2025 ACCC Innovator Award winners. For a deeper dive into this topic and other content that will help your team reimagine how care is delivered at your cancer program or practice, register today for the ACCC 42nd National Oncology Conference, October 15-17 in Denver, Colorado.    Resources:  Cancer Crushing Prevention and Early Detection  ACCC Recognizes National Cancer Prevention and Early Detection Month  Exploring Current Perceptions of Multi-Cancer Early Detection Testing Among Healthcare Providers  [PODCAST] Ep 05: Rural Cancer Care

    6 min
  4. 15 JUIL.

    Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes

    In this episode, CANCER BUZZ speaks with Andrew Munchel, MSN, RN, OCN, CPHQ, quality program administrator, oncology service line at WellSpan Health, WellSpan Cancer Institute about his program’s receipt of a 2025 ACCC Innovator Award. WellSpan Cancer Institute’s innovation, Adopting Machine Learning-Enabled Decision Support to Improve Oncology End-of-Life Outcomes, involved the implementation of the End-of-Life Care Index, a machine learning and cognitive computing model that predicts 12-month mortality risk, into the cancer program’s clinical decision support tool. Driven by a desire to address the underutilization of palliative care, Munchel will discuss how this implementation enhanced both the efficiency and effectiveness of WellSpan Cancer Institute’s care delivery. Andrew Munchel, MSN, RN, OCN, CPHQ Quality Program Administrator, Oncology Service Line WellSpan Health, WellSpan Cancer Institute York, Pennsylvania “Our innovation looked at how [we could] better predict who is most likely to benefit from [palliative care] conversations, queue them up, and have them at the appropriate times to link those patients to palliative care.” This podcast is part of a special series featuring the 2025 ACCC Innovator Award winners. For a deeper dive into this topic and other content that will help your team reimagine how care is delivered at your cancer program or practice, register today for the ACCC 42nd National Oncology Conference, October 15-17 in Denver, Colorado. Resources: Spirituality and Cultural Humility: Core Components of Comprehensive Palliative Care Collaborative Care: A Model for Embedding Counseling in Oncology and Palliative Care Building a Palliative Care Program from the Inside Out Early Palliative Care Program Proactively Meets Patient Needs

    5 min
  5. 10 JUIL.

    Ambulatory Care Excellence (ACE): Charting a New Path in Ambulatory Care Model and Coordination

    In this episode, CANCER BUZZ speaks with Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC, chief nursing officer and vice president of Nursing and Patient Care Services at Fox Chase Cancer Center about her program’s receipt of a 2025 ACCC Innovator Award. Fox Chase Cancer Center’s innovation, Ambulatory Care Excellence (ACE): Charting a New Path in Ambulatory Care Model and Coordination, is a structured approach designed to improve efficiency, coordination, and patient outcomes in ambulatory cancer care while ensuring top of license scope of work for clinicians. Rodriguez will discuss key features of the ACE Model, its impact on patients with cancer, and notable results of the initiative.   Anna Liza Rodriguez, MSN, MHA, RN, OCN, NEA-BC  Chief Nursing Officer, Vice President, Nursing and Patient Care Services  Fox Chase Cancer Center  Philadelphia, PA  “All of our team members are really connected to our purpose...from frontline staff to executives to different support services. [They] truly have the patient front and center, [and] that really drives a lot of our passion towards improvement [and] making sure that the care we deliver is exceptional.”  - Anna Rodriguez    This podcast is part of a special series featuring the 2025 ACCC Innovator Award winners. For a deeper dive into this topic and other content that will help your team reimagine how care is delivered at your cancer program or practice, register today for the ACCC 42nd National Oncology Conference, October 15-17 in Denver, Colorado.    Resources:  Geriatric Oncology Ambulatory Care Clinics  Implementing Telephone Triage Guidelines into Nursing Workflow  The Oncology Nursing Fellowship Program  Transitioning Select Chemotherapeutics to the Outpatient Setting Improves Care and Reduces Costs

    8 min
5
sur 5
30 notes

À propos

CANCER BUZZ features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Vous aimeriez peut‑être aussi